148 followers
9-18-2020: In a study released today from Philadelphia, Pennsylvania, good news for Actemra (tocilizumab) for treating just 1 already-immunodeficient patient who suffered from aplastic anemia and now, cytokine storm from COVID-19: https://t.co/YEheh0UcHI